1. Home
  2. LSTA vs YOSH Comparison

LSTA vs YOSH Comparison

Compare LSTA & YOSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • YOSH
  • Stock Information
  • Founded
  • LSTA 1980
  • YOSH 2016
  • Country
  • LSTA United States
  • YOSH United States
  • Employees
  • LSTA N/A
  • YOSH N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • YOSH Restaurants
  • Sector
  • LSTA Health Care
  • YOSH Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • YOSH Nasdaq
  • Market Cap
  • LSTA 22.3M
  • YOSH 23.7M
  • IPO Year
  • LSTA N/A
  • YOSH 2022
  • Fundamental
  • Price
  • LSTA $2.17
  • YOSH $1.43
  • Analyst Decision
  • LSTA Strong Buy
  • YOSH
  • Analyst Count
  • LSTA 2
  • YOSH 0
  • Target Price
  • LSTA $23.50
  • YOSH N/A
  • AVG Volume (30 Days)
  • LSTA 25.5K
  • YOSH 204.9K
  • Earning Date
  • LSTA 08-07-2025
  • YOSH 08-20-2025
  • Dividend Yield
  • LSTA N/A
  • YOSH N/A
  • EPS Growth
  • LSTA N/A
  • YOSH N/A
  • EPS
  • LSTA N/A
  • YOSH N/A
  • Revenue
  • LSTA $1,070,000.00
  • YOSH $13,902,861.00
  • Revenue This Year
  • LSTA N/A
  • YOSH N/A
  • Revenue Next Year
  • LSTA N/A
  • YOSH N/A
  • P/E Ratio
  • LSTA N/A
  • YOSH N/A
  • Revenue Growth
  • LSTA N/A
  • YOSH 30.39
  • 52 Week Low
  • LSTA $1.87
  • YOSH $0.68
  • 52 Week High
  • LSTA $4.20
  • YOSH $5.63
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 37.46
  • YOSH 41.96
  • Support Level
  • LSTA $2.55
  • YOSH $1.22
  • Resistance Level
  • LSTA $2.63
  • YOSH $1.95
  • Average True Range (ATR)
  • LSTA 0.17
  • YOSH 0.16
  • MACD
  • LSTA -0.04
  • YOSH 0.02
  • Stochastic Oscillator
  • LSTA 17.86
  • YOSH 28.77

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About YOSH Yoshiharu Global Co.

Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.

Share on Social Networks: